Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 13, Issue 3, 2000, Pages 191-197

  Szumilo, J ^a   Chibowski, D ^a   Dabrowski, A ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; PROTEIN BCL 2; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG RESPONSE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINIZATION; LYMPH NODE METASTASIS; MALE; MITOSIS INDEX; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TISSUE DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034491414     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2000.00110.x     Document Type: Article

References (36)

1. Combined modality therapy in the treatment of esophageal cancer
2. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary
3. Surgery, radiotherapy and chemotherapy for esophageal cancer
4. Cancer of the esophagus
5. Activation of programmed cell death by anticancer agents. Cisplatin as a mode system
6. Molecular mechanisms of drug resistance in tumours
7. p53 status and the efficacy of cancer therapy in vivo
8. The protooncogene bcl-2 and its role in regulating apoptosis
9. bcl-2: Role in epithelial differentiation and oncogenesis
10. p53 in life and death
11. Structure and function of the p53 tumor suppressor gene: Clue for rational cancer therapeutic strategies
12. Esophageal squamous carcinoma
13. Carcinoma of the esophagus: CT vs MR imaging in determing resectibility
14. Oesophagus
15. Histological typing of oesophageal and gastric tumours
16. Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma
17. Histopathological evaluation of response to pre-operative concurrent chemoradiotherapy for advanced esquamous cell carcinoma of the thoracic esophagus
18. Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma
19. The clinical and histopathological contributing factors influencing the effectiveness of preoperative hypertermo-chemo-radiotherapy for the patients with esophageal cancer
20. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma
21. Multivariante analysis of prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53
22. Clinocopathologic features of patients with oesophageal cancer obtaining histological complete response for preoperative hyperthermo-chemo-radiotherapy
23. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: Do histological assessment and p53 overexpression predict chemo-responsiveness?
24. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma
25. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
26. Expression of p53 protein in squamous cell carcinoma of the oesophagus (SCCE). Prognostic significance
27. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy
28. Clinical significance of p53, nm23 and bcl-2 in T3-4, N1M0 oesophageal carcinoma: An immunohistochemical approach
29. Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus
30. Expression of apoptosis-regulating proteins and outcome of eosophageal cancer patients treated by combined therapy modalities
31. The effect of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma
32. Expression of bcl-2, p53 and p21 in benign and malignant prostatic tissue before and after radiation therapy
33. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung carcinoma
34. Apoptosis and expression of p53 and Ki67 in squamous carcinoma of the oesophagus before and shortly after treatment with systemic chemotherapy
35. Detection of apoptosis-suppresing oncoprotein bcl-2 in hormone-refractory human prostate cancers
36. Differentiation of neuroblastoma enhances bcl-2 expression and induces alterations of apoptosis and drug resistance